Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

August 01, 2019; Volume 16,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Ahmadian, Mohammad Reza

    1. You have access
      From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers
      Mahsa Saliani, Razieh Jalal and Mohammad Reza Ahmadian
      Cancer Biology & Medicine August 2019, 16 (3) 435-461; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0530
  2. Bao, Huijing

    1. You have access
      Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
      Wei Li, Chengfeng Bi, Yating Han, Tian Tian, Xianhuo Wang, Huijing Bao, Xiaoying Xu, Xuhan Zhang, Lu Liu, Weiwei Zhang, Hai Gao, Huaqing Wang, Huilai Zhang, Bin Meng, Xi Wang and Kai Fu
      Cancer Biology & Medicine August 2019, 16 (3) 530-541; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0380
  3. Bi, Chengfeng

    1. You have access
      Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
      Wei Li, Chengfeng Bi, Yating Han, Tian Tian, Xianhuo Wang, Huijing Bao, Xiaoying Xu, Xuhan Zhang, Lu Liu, Weiwei Zhang, Hai Gao, Huaqing Wang, Huilai Zhang, Bin Meng, Xi Wang and Kai Fu
      Cancer Biology & Medicine August 2019, 16 (3) 530-541; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0380
  4. Bian, Xiuwu

    1. You have access
      A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
      Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian
      Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
  5. Cai, Juan

    1. You have access
      A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
      Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian
      Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
  6. Cao, Mianfu

    1. You have access
      A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
      Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian
      Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
  7. Chen, Chunfa

    1. You have access
      Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer
      Chunfa Chen, Yuling Zhang, Ziyi Huang, Jundong Wu, Wenhe Huang and Guojun Zhang
      Cancer Biology & Medicine August 2019, 16 (3) 575-586; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0423
  8. Chen, Fan

    1. You have access
      Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271
      Weiyu Shen, Yumei Li, Bifei Li, Liping Zheng, Xiaodong Xie, Jingqing Le, Yusheng Lu, Tao Li, Fan Chen and Lee Jia
      Cancer Biology & Medicine August 2019, 16 (3) 498-513; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0073
  9. Chen, Lu

    1. You have access
      A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
      Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian
      Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
  10. Chen, Peng

    1. You have access
      Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
      Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu and Chengping Hu
      Cancer Biology & Medicine August 2019, 16 (3) 556-564; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0506
« Previous (Pages : 1 2 3 4 5 6 ... 15) Next »
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 16 (3)
Cancer Biology & Medicine
Vol. 16, Issue 3
1 Aug 2019
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire